Nexgel Inc (NXGL)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $2.08M
Last updated: Nov 17, 2026 at 4:15 PM ET
Nexgel Inc (NXGL) Statistics
Nexgel (NXGL) has a market cap of $2.08M and an enterprise value of $7.81M. Its share count is up 22.28% from a year earlier. Its net debt of $5.73M equals 275.56% of its market cap.
Total Valuation
Enterprise value is 275.56% above the market cap, as debt exceeds cash.
| Market Cap | $2.08M |
|---|---|
| Enterprise Value | $7.81M |
| Latest price (Nov 17, 2026) | $3.80 |
Key Dates
The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 29, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 16, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.2x and 0.4x. Its year-end P/S ranged from 20.0x to 117.9x from 2021 to 2025.
| P/S Ratio | 0.2x |
|---|---|
| Forward P/S | 0.1x |
| P/B Ratio | 0.4x |
Enterprise Valuation
Counting debt and cash, the company is valued at 1.3x EBITDA.
| EV / Sales | 0.6x |
|---|---|
| EV / EBITDA | 1.3x |
Price Statistics
The stock is down 90.05% over 52 weeks and trades 14.03% below its 50-day average.
| Beta (1Y) | 0.16 |
|---|---|
| 52-Week Change | -90.05% |
| 1-Month Change | -34.48% |
| 3-Month Change | -52.96% |
| 6-Month Change | -69.05% |
| Total Return (1Y) | -90.05% |
| Total Return (3Y CAGR) | -52.56% |
| Return vs SPY (1Y) | -100.88% |
| Max Drawdown (1Y) | -92.06% |
| Max Drawdown (3Y) | -96.96% |
| Sharpe Ratio (1Y) | -1.71 |
| Correlation with SPY (1Y) | 0.02 |
| 50-Day Average | $4.42 |
| 200-Day Average | $10.89 |
| 52-Week Range | $3.00 to $40.40 |
| RSI (14 Days) | 45.3 |
| Average Volume (20 Days) | 38.39K |
Financial Position
Current assets cover 0.46x current liabilities, and total debt is 1.46x shareholder equity.
| Current Ratio | 0.46x |
|---|---|
| Quick Ratio | 0.21x |
| Debt / Equity | 1.46x |
| Debt / EBITDA | 1.02x |
Returns and Efficiency
Return on invested capital is -10.08% over the last 12 months, against a 5-year average of -35.36%.
| Return on Equity (ROE) | -157.41% |
|---|---|
| Return on Assets (ROA) | -27.19% |
| Return on Invested Capital (ROIC) | -10.08% |
| Return on Capital Employed (ROCE) | -9.74% |
| ROE (5Y Average) | -58.14% |
| ROA (5Y Average) | -32.48% |
| ROIC (5Y Average) | -35.36% |
| Asset Turnover | 0.69x |
| Inventory Turnover | 3.25x |
| Receivables Turnover | 13.08x |
| Cash Conversion Cycle | -42 days |
Scores
NXGL has an Altman Z-Score of -1.45, in the distress zone below 1.81, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -1.45 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $12.31M over the last 12 months is up 5.54% from the 12 months before.
| Revenue | $12.31M |
|---|---|
| Revenue Growth (YoY) | +5.54% |
| Gross Profit | $4.12M |
| Operating Income | -$7.22M |
| Pretax Income | -$6.50M |
| Net Income | -$6.50M |
| EBITDA | $5.90M |
| EBIT | -$1.29M |
| Reported EPS (TTM) | -$2.94 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 17.28% of the $23.90M in total assets.
| Cash and Equivalents | $278.00K |
|---|---|
| Total Debt | $6.01M |
| Net Debt | $5.73M |
| Net Debt Per Share | $11.76 |
| Working Capital | -$5.69M |
| Shareholder Equity | $4.13M |
| Book Value Per Share | $8.47 |
| Tangible Book Value | -$9.34M |
| Total Assets | $23.90M |
| Total Liabilities | $19.23M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $157.00K of capital spending, operating cash flow left -$3.71M of free cash flow.
| Operating Cash Flow | -$3.55M |
|---|---|
| Capital Expenditures | $157.00K |
| Free Cash Flow | -$3.71M |
| FCF Per Share | -$6.92 |
| Depreciation and Amortization | $7.20M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -58.61%, against a 5-year average of -96.89%.
| Gross Margin | 33.42% |
|---|---|
| Operating Margin | -58.61% |
| Pretax Margin | -52.78% |
| Net Margin | -52.78% |
| EBITDA Margin | 47.94% |
| EBIT Margin | -10.50% |
| FCF Margin | -30.12% |
| Gross Margin (5Y Average) | 18.65% |
| Operating Margin (5Y Average) | -96.89% |
Growth
Revenue grew 77.33% a year over 3 years.
| Revenue Growth (3Y CAGR) | +77.33% |
|---|---|
| Revenue Growth (5Y CAGR) | +76.12% |
| Book Value Per Share Growth (2Y CAGR) | -16.68% |
| Tangible Book Per Share Growth (2Y CAGR) | -22.70% |
Dividends and Yields
NXGL does not pay a dividend. Its free cash flow yield is -200.22%.
| FCF Yield | -200.22% |
|---|---|
| Buyback Yield | 4.97% |
| Shareholder Yield | 4.97% |
Stock Splits
The last split was a 1-for-20 reverse split on Oct 12, 2026.
| Last Split Date | Oct 12, 2026 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:20 |
Peer Position
Against 7 similar companies, NXGL has the lowest P/S.
P/S RatioPeer median 1.5x
ROICPeer median -31.39%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +9.24%
| P/S Ratio | 0.2x vs 1.5x median |
|---|---|
| ROIC | -10.08% vs -31.39% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +5.54% vs +9.24% median |
Analyst Forecast
Consensus estimates put revenue growth at 45.77% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +45.77% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About NXGL
What is NXGL's market cap?
Nexgel has a market cap of $2.08M. Its enterprise value, which adds debt and subtracts cash, is $7.81M.
How many shares of NXGL are outstanding?
Nexgel has 487.36K shares outstanding. The count is up 22.28% from a year earlier.
Does NXGL pay a dividend?
No. Nexgel does not pay a dividend.
How much debt does NXGL have?
Nexgel has $6.01M of total debt and $278.00K of cash and equivalents, a net debt position of $5.73M.
NXGL pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors